Lilly's Competitive Clinical Research Grant
Lilly's Competitive Clinical Research Grant funds independent clinical research in Eli Lilly and Company's scientific priority areas, supporting rigorous investigator-led studies.
Funder: Eli Lilly and Company
Due Dates (Anticipated): March 2027 (Full application deadline, projected)
Funding Amounts: Funding varies by project; supports full costs of independent clinical research studies aligned with RFP scope.
Summary: Supports independent investigator-initiated clinical research in Lilly’s areas of interest, with proposals reviewed by expert committees.
Description
Lilly's Competitive Clinical Research Grant is designed to fund external, investigator-initiated clinical research studies that address scientific areas of interest to Eli Lilly and Company. The program operates through publicly posted Requests for Proposals (RFPs), each outlining a specific research focus and submission timeline. Proposals are reviewed by global committees of Lilly’s medical and scientific experts, sometimes with additional external reviewer input. Grantees maintain full independence and responsibility for study design, conduct, and regulatory oversight, ensuring research integrity. This grant is suitable for researchers aiming to conduct rigorous, independent clinical studies aligned with Lilly’s published priorities.
